SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy—Is there a link?

Clinical manifestations of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can include gastrointestinal signals and symptoms. Individuals with previous clinical conditions that usually enroll gut dysbiosis have been identified as being at high risk to develop more seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Balmant, Bianca D., Torrinhas, Raquel S., Rocha, Ilanna M., Fonseca, Danielle C., Formiga, Francisco F.C., Bonfá, Eloisa S.D.O., Borba, Eduardo F., Waitzberg, Dan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832980/
https://www.ncbi.nlm.nih.gov/pubmed/33545540
http://dx.doi.org/10.1016/j.nut.2020.111115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832980/
https://www.ncbi.nlm.nih.gov/pubmed/33545540
http://dx.doi.org/10.1016/j.nut.2020.111115

Ejemplares similares